Boceta, JDe la Torre, ASamper, DFarto, MSánchez-de la Rosa, R2023-01-252023-01-252016http://hdl.handle.net/10668/9818There is no unanimous consensus on the clinical features to define breakthrough cancer pain (BTcP). The current project aimed to investigate the opinion of a panel of experts on cancer pain on how to define, diagnose, assess, treat and monitor BTcP. A two-round Spanish multi-centre exploratory Delphi study was conducted with medical experts (n = 90) previously selected from Medical Oncology Services, Radiation Oncology, Palliative Care/Home Care Teams, and Pain Units. The study intended to seek experts' consensus and to define a set of recommendations for the management of BTcP. It was generally agreed that, definition of BTcP implies that baseline pain should be controlled (84 %), although not necessarily with opioids (only 30 %); there must be exacerbations (98.9 %); the duration of each episode should last The present Delphi study identified a set of recommendations to define, assess and monitor BTcP.enAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/Baseline cancer painBreakthrough cancer painCancerConsensusDelphiManagementBreakthrough PainCancer PainConsensusDelphi TechniquePain Managementresearch article26856600open access10.1007/s12094-016-1490-41699-3055PMC5059417https://link.springer.com/content/pdf/10.1007%2Fs12094-016-1490-4.pdfhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5059417/pdf